Angelo Carpethos
Medical · East Providence, RINPI 1518056795
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $21.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Nestle Healthcare Nutrition Inc.$831
- AstraZeneca$630
- GSK$573
- Pfizer$359
- Amgen$296
- plus $1K from 20 others
What the payments were for
- Food & beverage$5,196100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 56 | $1,079 |
| Nestle Healthcare Nutrition Inc. | 35 | $831 |
| AstraZeneca | 23 | $630 |
| GSK | 31 | $573 |
| Pfizer | 18 | $359 |
| Amgen | 12 | $296 |
| Paratek Pharmaceuticals, Inc. | 7 | $295 |
| Biohaven Pharmaceuticals, Inc. | 6 | $169 |
| Novo Nordisk | 8 | $134 |
| Idorsia Pharmaceuticals US Inc | 6 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $87 |
| Lilly USA, LLC | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 5 | $73 |
| Genentech USA, Inc. | 6 | $73 |
| Merz North America, Inc. | 1 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $35 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Exact Sciences | 1 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Abbott | 1 | $26 |
| Boehringer Ingelheim | 1 | $25 |
| Antares Pharma, Inc. | 1 | $24 |
| Optinose US, Inc. | 1 | $23 |
| Bausch Health US, LLC | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,196 in reported general payments places this provider in the 90th percentile of 77 medical providers in Rhode Island.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 19 | $26,832 |
| FarxigaDapagliflozin Propanediol | 11 | $18,137 |
| LinzessLinaclotide | 11 | $17,377 |
| OzempicSemaglutide | 11 | $14,887 |
| Fentanyl | 48 | $11,833 |
| EliquisApixaban | 13 | $11,649 |
| UbrelvyUbrogepant | 11 | $10,185 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 184 | $2,486 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 82 | $2,321 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 84 | $1,879 |
| Ventolin HfaAlbuterol Sulfate | 30 | $1,513 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 44 | $1,458 |
| Atorvastatin Calcium | 80 | $1,290 |
| Omeprazole | 82 | $1,246 |
| ValacyclovirValacyclovir Hcl | 16 | $1,213 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Ubrelvy | $1,079 | $27,56222 claims |
| Lilly USA, LLCTrulicity | $84 | $26,83219 claims |
| AstraZenecaFarxiga | $630 | $18,13711 claims |
| Novo NordiskOzempic | $134 | $14,88711 claims |
| PfizerEliquis | $359 | $11,64913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 77 medical providers in Rhode Island.
Other medical in East Providence
- Steven OcchiutiEast Providence$2K
- Walter DelucaEast Providence$1K
- Michael AntoineEast Providence$713
- Taylor ReallEast Providence$56
- Paul MallariJohnston$27K
- Shane MorganLincoln$24K
- Nancy StaleyWesterly$17K
- Amanda MattesonProvidence$8K
- Jason XynellisProvidence$7K
- Dhara ShahSmithfield$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.